MiS checkmates a chronic diabetic ulcer: a clinical case

12 October 2021 - Research -
Share

After having been tried and widely used for treating wounds with appreciable results, MLS® Laser Therapy with the MiS device provided positive results also when treating a chronic diabetic ulcer.

The simultaneous action of two different wavelengths with high peak power which characterise the equipment in fact produces analgesic, anti-inflammatory and anti-oedema effects which proved to be important for effectively managing the disease and for facilitating healing of both superficial and deep tissues.

This is confirmed by a 65-year old patient suffering from type 2 diabetes with a chronic ulcer to the right ankle caused by the disease. Initially undergoing drug therapy and dedicated surveillance with no appreciable results, the patient then underwent MLS® Laser Therapy: 20 sessions (4 per week lasting 2 minutes each) with the MiS device (“superficial wound” protocol), followed by simple medication, which after just a few sessions led to an evident improvement in the ulcer, up to its complete closure at the end of the cycle.

Furthermore, subsequent follow-ups at 1 and 2 months showed a full recovery of the skin barrier and the absence of inflammation.

Testo a Destra
Immagine 30%/Testo 60%
Ulcer wound healing with MiS laser device

“Healing of Leg Diabetic ulcer treated with MLS-MiS laser (MiS – MLS® High Peak Pulse): a case report”
T. Viliani, B. Lombardi
Energy For Health [21], 2021

READ MORE

You might also be interested in ...

See all articles

Energy for Health - Scientific review by ASAcampus
news - 01/10/2021
Four case reports dedicated to applying the MLS® therapy, two in the human field and two in the veterinary field are the focus of the new edition of Energy for Health.
Effect of NIR Laser Therapy by MLS‐MiS Source on Fibroblast Activation by Inflammatory Cytokines in Relation to Wound Healing
blog - 12/04/2021
The ASA device have an important anti-inflammatory effect, but it is also effective in controlling fibroblast activation induced by IL‐1β and TNF‐α, probably responsible for a detrimental effect on...
myelin thickness with MLS laser MiS
Research
L. Micheli, F. Cialdai, A. Pacini, J.J.V. Branca, L. Morbidelli, V. Ciccone, E. Lucarini, C. Ghelardini, M. Monici, L. Di Cesare Mannelli Nature Scientific Reports, 9:9297, 2019
Press - 23/01/2025
Anti-inflammatory, muscle relaxant and effective in rapidly reducing pain, MLS® Laser Therapy is the recommended therapy to successfully treat various muscular diseases.
Press - 23/01/2025
New valuable milestones for MLS® Laser Therapy, which is confirmed as a decisive therapy in pain management.
 Diabetic Peripheral Neuropathic Pain Using MiS MLS Laser
Blog - 23/01/2025
This clinical case highlights the effectiveness of using the MiS laser device on a 67-year-old woman who was diagnosed with type II diabetes mellitus in 2008.